Delivering on clinical need requirements
Hepatitis B virus (HBV) DNA detection and viral load measurement are essential for treatment decisions and patient monitoring.1 cobas® HBV for use on the cobas® 5800/6800/8800 Systems provides security in your results with primers and probes targeting the highly conserved pre-core and core regions of the HBV genome. The amplified region of the genome will not be affected by mutations that arise due to drug resistance.2
cobas® HBV provides robust, clinically relevant assay performance with a broad linear range and high sensitivity, delivering optimal results throughout critical medical decision points and across all genotypes combined with a highly efficient laboratory workflow.1,3
Roche has been at the forefront of viral load monitoring tests for hepatitis and continues to provide a robust assay design to ensure accurate and reliable results to improve patient management and treatment success.
Highly optimized primer-probe selection
HBV DNA detection and viral load measurement are essential for the diagnosis, decision to treat and subsequent monitoring of patients.4
Roche primers and probes target the highly conserved pre-core and core regions of the HBV genome. The amplified region of the genome will not be affected by mutations that arise due to drug resistance.5
- Excellent performance with serum and plasma specimens
- Built-in contamination control with AmpErase enzyme to prevent carryover contamination
- Excellent correlation to Roche COBAS® AmpliPrep/COBAS® TaqMan® HBV Test, v2.0
A critical assessment tool for long term patient monitoring
Roche hepatitis assays deliver robust, clinically relevant performance with a broad linear range, high sensitivity and optimal results within a fully automated workflow.